Detalhe da pesquisa
1.
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.
Respirology
; 23(8): 771-779, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611244
2.
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
Pulm Circ
; 12(3): e12120, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911181
3.
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
J Heart Lung Transplant
; 39(5): 464-472, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32008947
4.
Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.
Am J Respir Crit Care Med
; 178(10): 1060-5, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18755927
5.
Long-term outcomes of the bronchial artery embolization are diagnosis dependent.
Lung India
; 33(1): 3-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933299